BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14979600)

  • 1. Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan.
    Ikebe T; Murayama S; Saitoh K; Yamai S; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Tamaru A; Katayama A; Fujinaga Y; Hoashi K; Watanabe H;
    Epidemiol Infect; 2004 Jan; 132(1):145-9. PubMed ID: 14979600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Diversity in Streptococcus dysgalactiae subsp. equisimilis Isolates from Patients with Invasive and Noninvasive Infections in a Japanese University Hospital (2014-2015).
    Fujita T; Horiuchi A; Ogawa M; Yoshida H; Hirose Y; Nagano N; Takahashi T
    Jpn J Infect Dis; 2017 Jan; 70(1):100-104. PubMed ID: 27000456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic diversity and virulence properties of Streptococcus dysgalactiae subsp. equisimilis from different sources.
    Gherardi G; Imperi M; Palmieri C; Magi G; Facinelli B; Baldassarri L; Pataracchia M; Creti R
    J Med Microbiol; 2014 Jan; 63(Pt 1):90-98. PubMed ID: 24149625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of emm types and antimicrobial susceptibility of Streptococcus dysgalactiae subsp. equisimilis in Austria.
    Leitner E; Zollner-Schwetz I; Zarfel G; Masoud-Landgraf L; Gehrer M; Wagner-Eibel U; Grisold AJ; Feierl G
    Int J Med Microbiol; 2015 Dec; 305(8):918-24. PubMed ID: 26507866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of virulence factors and association with emm polymorphism or isolation site among beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis.
    Lo HH; Cheng WS
    APMIS; 2015 Jan; 123(1):45-52. PubMed ID: 25244428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus dysgalactiae subsp. equisimilis from invasive and non-invasive infections in Spain: combining epidemiology, molecular characterization, and genetic diversity.
    Rojo-Bezares B; Toca L; Azcona-Gutiérrez JM; Ortega-Unanue N; Toledano P; Sáenz Y
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1013-1021. PubMed ID: 33392783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of group G Streptococcus dysgalactiae subsp. equisimilis recovered from patients and healthy people in China.
    Yin J; Yu S; Liu X; Li Y; Gao W; Zhou L; Ji L; Shen X; Yang Y
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):41-6. PubMed ID: 22078907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of invasive Streptococcus dysgalactiae subsp. equisimilis. Multicenter study: Argentina 2011-2012.
    Traverso F; Blanco A; Villalón P; Beratz N; Sáez Nieto JA; Lopardo H;
    Rev Argent Microbiol; 2016; 48(4):279-289. PubMed ID: 28341023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen.
    Tanaka D; Isobe J; Watahiki M; Nagai Y; Katsukawa C; Kawahara R; Endoh M; Okuno R; Kumagai N; Matsumoto M; Morikawa Y; Ikebe T; Watanabe H;
    J Clin Microbiol; 2008 Apr; 46(4):1526-9. PubMed ID: 18305132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness.
    Pinho MD; Melo-Cristino J; Ramirez M
    J Clin Microbiol; 2006 Mar; 44(3):841-6. PubMed ID: 16517864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Characterization of Invasive Streptococcus dysgalactiae subsp. equisimilis, Japan.
    Wajima T; Morozumi M; Hanada S; Sunaoshi K; Chiba N; Iwata S; Ubukata K
    Emerg Infect Dis; 2016 Feb; 22(2):247-54. PubMed ID: 26760778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Characteristics of
    Fujita T; Yoshida H; Osaka S; Hirose Y; Goto M; Nagano N; Takahashi T
    Ann Lab Med; 2019 Sep; 39(5):488-492. PubMed ID: 31037868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of virulence genes to clinical manifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia.
    Tsai CT; Chi CY; Ho CM; Lin PC; Chou CH; Wang JH; Wang JH; Lin HC; Tien N; Lin KH; Ho MW; Lu JJ
    J Microbiol Immunol Infect; 2014 Dec; 47(6):462-8. PubMed ID: 24210866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and antibiotic resistance of clinical Streptococcus dysgalactiae subsp. equisimilis in Beijing, China.
    Lu B; Fang Y; Huang L; Diao B; Du X; Kan B; Cui Y; Zhu F; Li D; Wang D
    Infect Genet Evol; 2016 Jun; 40():119-125. PubMed ID: 26925701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the ska gene in emm49-genotyped Streptococcus pyogenes strains isolated from patients with severe invasive streptococcal infections.
    Ikebe T; Endoh M; Watanabe H
    Jpn J Infect Dis; 2005 Oct; 58(5):272-5. PubMed ID: 16249619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections.
    Brandt CM; Schweizer KG; Holland R; Lütticken R; Freyaldenhoven BS
    Int J Med Microbiol; 2005 Dec; 295(8):539-46. PubMed ID: 16325550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings.
    Siljander T; Karppelin M; Vähäkuopus S; Syrjänen J; Toropainen M; Kere J; Vuento R; Jussila T; Vuopio-Varkila J
    Clin Infect Dis; 2008 Mar; 46(6):855-61. PubMed ID: 18260753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Complement-Mediated Cell Lysis-like Gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis Isolates From Japan (2014-2016).
    Takahashi T; Fujita T; Shibayama A; Tsuyuki Y; Yoshida H
    Ann Lab Med; 2017 Jul; 37(4):297-304. PubMed ID: 28445008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiological investigation of an outbreak of invasive beta-haemolytic streptococcal infection in western Norway.
    Mylvaganam H; Bruun T; Vindenes HA; Langeland N; Skrede S
    Clin Microbiol Infect; 2009 Mar; 15(3):245-52. PubMed ID: 19178544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Streptococcus pyogenes causing invasive disease in Portugal: evidence for superantigen gene loss and acquisition.
    Friães A; Lopes JP; Melo-Cristino J; Ramirez M;
    Int J Med Microbiol; 2013 Dec; 303(8):505-13. PubMed ID: 23932912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.